期刊文献+

骨水泥的遗传毒性研究 被引量:3

Genotoxicity Study of Bone Cement
下载PDF
导出
摘要 目的检测医疗器械进口产品骨水泥的遗传毒性。材料与方法以骨水泥粉体浸提液与其液体混合液为供试液,采用细菌回复突变试验(Ames试验)和小鼠淋巴瘤细胞试验(MLA),在非代谢活化(-S9)和代谢活化(+S9)条件下检测。Ames试验采用平板掺入法,检测了25、50、100 ml/皿3个剂量组诱发鼠伤寒沙门氏菌(S.typhimurium)TA98、TA100、TA1535、TA1537及大肠杆菌(E.coli)WP2 uvrA的回变菌落数;MLAT采用微孔法检测了终浓度0.125%、0.25%、0.5%(V/V)3个浓度组,在+S9/3 h、-S9/3 h、-S9/24 h三种处理条件下诱发L5178Y细胞tk+/-基因突变频率(MF)和小集落突变百分率(SC%)。结果 Ames试验,50、100 ml/皿剂量组在加入磷酸缓冲液或S9混合液后略有沉淀产生,并对TA100、TA1535、WP2 uvrA产生不同程度的抑菌作用,无抑菌剂量诱发五株菌的回变菌落数对比DMSO溶媒(阴性)对照组,均无明显增加;MLA,各浓度组在三种处理条件下诱发的MF、SC%与其溶媒(阴性)对照组比较,无明显增加(P>0.05)。结论本实验条件下,骨水泥对测试菌株his-/trp-无明显诱变作用,对测试细胞tk+/-及染色体无明显损伤作用。 Objective To investigate the genotoxicity of bone cement. Material and Methods Test article was mixed of liquid and the powder extract of bone cement. Using bacterial reverse mutation test (Ames test) and mouse lymphoma Assay (MLA) with and without metabolic activation S9. Ames test was performed by the plate incorporation method for its ability to induce reverse mutations in three treatment dosage groups: 25 μl/plate, 50 μl/plate, 100 μl/plate using S. typhimurium TA98. TA100. TA1535 TA1537 and E. coil WP2 uvrA; In MLA, the mutation frequency (MF) and the percentage of small colony mutants (SC%) of L5178 tk+/- cells induced by bone cement at final concentration of 0.125%, 0.25% and 0.5% (V/V) were calculated and assayed with +S9/3 h, -S9/3 h, -S9/24 h. Results Slight precipitations of two dosage group 50 μl/plate and 100 μl/plate were observed after phosphoric acid buffer solution or S9mix added. Growth inhibition effect exists in TA100, TA1535 and WP2 uvrA to varying degrees. Other groups did not cause obvious increases in the mean number of revertant per plate compared with negative control (DMSO). The result of MLA indicated no significant MF or SC% increases (P〉0.05) observed comparing with negative control under all test conditions. Conclusions The bone cement did not induce reverse mutation at his-/trp- and there was no obvious damage effect to gene tk+/- or chromosome under this study condition.
出处 《中国医疗器械杂志》 CAS 2011年第6期425-427,445,共4页 Chinese Journal of Medical Instrumentation
关键词 骨水泥 细菌回复突变试验 小鼠淋巴瘤细胞试验 遗传毒性 bone cement, bacterial reverse mutation test (Ames test), mouse lyrnphoma assay (MLA), genotoxicity.
  • 相关文献

参考文献15

  • 1法国TeknimedSAS公司.医疗器械注册产品标准YZB/Teknimed0001-2009[S].2009.
  • 2中华人民共和国国家标准GB/T16886.3-2008/IS010993-3:2003《医疗器械生物学评价第3部分:遗传毒性,致癌性和生殖毒性试验》[S].
  • 3中华人民共和国国家标准GB/T16886.12-2005/ISO10993-12:2002《医疗器械生物学评价第12部分:样品制备与参照样本》[S].
  • 4《药物遗传毒性研究技术指导原则》课题研究组.药物遗传毒性研究技术指导原则[S].2007.
  • 5OECD TG 471, Bacterial Reverse Mutation Test[S]. 1997.
  • 6OECD TG 476, In Vitro Mammalian Cell Gene Mutation Test[S]. 1997.
  • 7日本バィォアシヒィ研究センタ一微生物实验室.微生物さ用ぃる变异原性试验手法解就[M].第1刷.神奈川県秦野:中央勞動災害防止協会.日本バィォアシヒィ研究センタ一,199:16-17.
  • 8谢明.小鼠淋巴瘤细胞突变试验方法[J].癌变.畸变.突变,2003,15(3):183-186. 被引量:13
  • 9赵洁,胡燕平,宋捷,张旻,李波,邢瑞昌.小鼠淋巴瘤细胞基因突变方法的建立与应用[J].毒理学杂志,2006,20(4):268-269. 被引量:14
  • 10Martha M.Moore,et.al. mouse lymphoma thymidine kinase gene mutation assay: follow-up meeting of the international workshop on genotoxicity testing-aberdeen, scotland, 2003-assay acceptance criteria, positive controls, and data evaluation[J]. Environmental and Molecular Mutagenesis. 2006, 47: 1-5.

二级参考文献21

  • 1国家食品药品监督管理局.药物遗传毒性研究技术指导原则[S].2007.
  • 2Organisation for Economic Co-operation and Development. OECD guideline for testing of chemicals 471 : bacterial reverse mutation test[S]. 1997.
  • 3ICH Steering Committee. Harmonised tripartite guideline S2B: Genotoxicity:a standard battery for genotoxicity testing of pharmaceuticals [ S ]. 1997.
  • 4AMES B N, MCCANN J,YAMASAKI E. Methods for detecting carcinogens and mutagens with the Sahnonella/mammalian-microsome mutagenicity test [ J]. Murat Res, 1975, 31 (6) : 347 - 364.
  • 5MARON D M ,AMES BN. Revised methods for the Salmonella mutagenicity test [ J ]. Murat Res, 1983,113 ( 3 ) : 173 - 215.
  • 6日本バィォアツセィ研究セソタ一微生物試驗室.微生物を用ぃる変異原性試驗手法解說[M].神奈川県秦野:中央労慟災害防止協会 日本バィォアツセィ研究セソタ一,1999:70-71.
  • 7GATEHOUSE DG, ROWLAND IR, WILCOX P, et al. Bacterial mutation assay [ M ]//KIRKLAND DJ. basic mutagenicity tests: UKEMS recommended procedures. Cambridge: Cambridge University Press, 1990 : 13 - 61.
  • 8Müller L, Kikuchri Y, Probst G, et al. ICH - Harmonised guidances on genotoxicity testing of pharmaceuticals: evolution, reasoning and impact [J], Mutat Res, 1999,436: 195- 225.
  • 9OECD Guideline 476, In vitro Mammalian Cell Gene Mutation Test(R), OECD Documents, updated and adopted July 21, 1997.
  • 10Grant SG, Zhang YP, Klopman G, et al .Modeling the mouse lymphoma forward mutational assay: the Gene- Tox program database[J], Mutat Res, 2000,465:201 - 229.

共引文献29

同被引文献18

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部